Ứng dụng Tế Bào Gốc Trung Mô (MSCs) trong hỗ trợ ghép tạng MSC có thể phát triển nhanh chóng trong đĩa nuôi cấy, tiết ra rất nhiều yếu tố tăng trưởng và cytokine thông qua cơ chế cận tiết của chúng, và đã được theo đuổi vì khả năng tạo ra sự dung nạp cấy ghép. Việc truyền MSC từ cả nguồn tự thân và đồng loại như một liệu pháp tế bào đã được thực hiện nhờ khả năng giảm việc sử dụng thuốc ức chế miễn dịch ở những người nhận ghép tạng.

Transplant International ISSN 0934-0874 ORIGINAL ARTICLE Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation Norberto Perico,1,2* Federica Casiraghi,1,2* Eliana Gotti,1* Martino Introna,3 Marta Todeschini,1,2 Regiane Aparecida Cavinato,1,2 Chiara Capelli,3 Alessandro Rambaldi,4 Paola Cassis,1,2 Paola Rizzo,1 Monica Cortinovis,1,2 Marina Noris1,2 and Giuseppe Remuzzi1,2 1 Department of Immunology and Transplantation, Azienda Ospedaliera – IRCCS – Istituto di Ricerche Farmacologiche “Mario Negri”, Bergamo, Italy 2 Transplant Research Center,“Chiara Cucchi de Alessandri e Gilberto Crespi” Ranica, Bergamo, Italy 3 Laboratory of Cell Therapy “G. Lanzani”, Papa Giovanni XXIII, Bergamo, Italy 4 Department of Hematology, Papa Giovanni XXIII, Bergamo, Italy

Paracrine Action Enhances the Effects of Autologous Mesenchymal Stem Cell Transplantation on Vascular Regeneration in Rat Model of Myocardial Infarction Yao Liang Tang, MD, PhD, Qiang Zhao, MD, Xinyu Qin, MD, Leping Shen, BS, Leilei Cheng, MD, Junbo Ge, MD, and M. Ian Phillips, PhD, DsC Department of Physiology and Biophysics, College of Medicine, University of South Florida, St. Petersburg, Florida and Zhongshan Hospital, Fudan University, Shanghai, China

21:27 26/06/2023 Original Articles: Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibili... Clin J Am Soc Nephrol. 2011 Feb; 6(2): 412–422. doi: 10.2215/CJN.04950610: 10.2215/CJN.04950610 PMCID: PMC3052234 PMID: 20930086 Original Articles Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility Norberto Perico, Federica Casiraghi, Martino Introna, Eliana Gotti, Marta Todeschini, Regiane Aparecida Cavinato, Chiara Capelli, Alessandro Rambaldi, Paola Cassis, Paola Rizzo, Monica Cortinovis, Maddalena Marasà, Josee Golay, Marina Noris, and Giuseppe Remuzzi

Review Mesenchymal Stem/Stromal Cells in Organ Transplantation Dayanand Deo , Misty Marchioni and Prakash Rao *

21:34 26/06/2023 Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-rando... As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more about our disclaimer. Oncotarget. 2016 Mar 15; 7(11): 12089–12101. Published online 2016 Feb 25. doi: 10.18632/oncotarget.7725 PMCID: PMC4914271 PMID: 26933811 Low-dose tacrolimus combined with donor-derived mesenchymal stem cells after renal transplantation: a prospective, non-randomized study Guang-hui Pan, Zheng Chen, Lu Xu, Jing-hui Zhu, Peng Xiang, Jun-jie Ma, Yan-wen Peng, Guang-hui Li, Xiao-yong Chen, Jia-li Fang, Yu-he Guo, Lei Zhang, and Long-shan Liu

ORIGINAL CONTRIBUTION Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants A Randomized Controlled Trial Jianming Tan, MD, PhD Weizhen Wu, MD Xiumin Xu, MS Lianming Liao, PhD Feng Zheng, MD, PhD Shari Messinger, PhD Xinhui Sun, MD Jin Chen, BS Shunliang Yang, MD Jinquan Cai, MD Xia Gao, MD Antonello Pileggi, MD, PhD Camillo Ricordi, MD

REVIEW | The Journal of Clinical Investigation Stem cell therapy for muscular dystrophies Stefano Biressi,1,2 Antonio Filareto,3 and Thomas A. Rando4,5,6 Department of Cellular, Computational and Integrative Biology (CIBIO) and Dulbecco Telethon Institute, University of Trento, Povo, Italy. Department of Research Beyond Borders, Regenerative Medicine, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Conneticut, USA.  Department of Neurology and Neurological Sciences and Paul F. Glenn Center for the Biology of Aging, Stanford University School of Medicine, Stanford, California, USA. Center for Tissue Regeneration, Repair and Restoration, Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.

Chapter Mesenchymal Stem Cells for Regenerative Medicine for Duchenne Muscular Dystrophy Ahmed Elhussieny, Ken’ichiro Nogami, Fusako Sakai-Takemura, Yusuke Maruyama, AbdElraouf Omar Abdelbakey, Wael Abou El-kheir, Shin’ichi Takeda and Yuko Miyagoe-Suzuki

Tiềm năng của tế bào gốc trung mô trong điều trị loạn dưỡng cơ do di truyền Stem cell therapy for muscular dystrophies - PMC (nih.gov) (2020) Mesenchymal Stem Cells for Regenerative Medicine for Duchenne Muscular Dystrophy | IntechOpen (2020)